Mitogen-activated protein kinase phosphatase 2 regulates the inflammatory response in sepsis

Infection and Immunity

Volumn 78, Issue 6, 2010, Pages 2868-2876

  Cornell, Timothy T ^a   Rodenhouse, Paul ^a   Cai, Qing ^a   Sun, Lei ^a   Shanley, Thomas P ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 2; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BONE MARROW; CECUM; CYTOKINE PRODUCTION; ENZYME INACTIVATION; HYPOTHESIS; INFECTION; INFLAMMATION; INNATE IMMUNITY; LIGATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PUNCTURE; SEPSIS; SURVIVAL RATE; WILD TYPE;

ANIMALS; BACTERIAL INFECTIONS; CYTOKINES; DUAL SPECIFICITY PHOSPHATASE 1; FEMALE; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MAP KINASE KINASE 4; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERITONITIS; PROTEIN TYROSINE PHOSPHATASES; SEPSIS; SURVIVAL ANALYSIS;

EID: 77952725007     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00018-10     Document Type: Article

References (29)

1. Abraham, E., and M. Singer. 2007. Mechanisms of sepsis-induced organ dysfunction. Crit. Care Med. 35:2408-2416.
2. Angus, D. C., W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky. 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29:1303-1310.
3. Bhalla, U. S., P. T. Ram, and R. Iyengar. 2002. MAP kinase phosphatase as a locus of flexibility in a mitogen-activated protein kinase signaling network. Science 297:1018-1023. (Pubitemid 34856036)
4. Bone, R. C. 1996. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit. Care Med. 24:1125-1128.
5. Brondello, J. M., A. Brunet, J. Pouyssegur, and F. R. McKenzie. 1997. The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44MAPK cascade. J. Biol. Chem. 272:1368-1376.
6. Brondello, J. M., J. Pouyssegur, and F. R. McKenzie. 1999. Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation. Science 286:2514-2517. (Pubitemid 30026341)
7. Caunt, C. J., S. P. Armstrong, C. A. Rivers, M. R. Norman, and C. A. McArdle. 2008. Spatiotemporal regulation of ERK2 by dual specificity phosphatases. J. Biol. Chem. 283:26612-26623.
8. Chen, P., D. Hutter, P. Liu, and Y. Liu. 2002. A mammalian expression system for rapid production and purification of active MAP kinase phosphatases. Protein Expr. Purif. 24:481-488.
9. Chen, P., J. Li, J. Barnes, G. C. Kokkonen, J. C. Lee, and Y. Liu. 2002. Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J. Immunol. 169:6408-6416. (Pubitemid 36903490)
10. Chi, H., S. P. Barry, R. J. Roth, J. J. Wu, E. A. Jones, A. M. Bennett, and R. A. Flavell. 2006. Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc. Natl. Acad. Sci. U. S. A. 103:2274-2279.
11. Chu, Y., P. A. Solski, R. Khosravi-Far, C. J. Der, and K. Kelly. 1996. The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation. J. Biol. Chem. 271:6497-6501.
12. Dong, C., R. J. Davis, and R. A. Flavell. 2002. MAP kinases in the immune response. Annu. Rev. Immunol. 20:55-72.
13. Guan, K. L., and E. Butch. 1995. Isolation and characterization of a novel dual specific phosphatase, HVH2, which selectively dephosphorylates the mitogen-activated protein kinase. J. Biol. Chem. 270:7197-7203.
14. Hammer, M., J. Mages, H. Dietrich, A. Servatius, N. Howells, A. C. Cato, and R. Lang. 2006. Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. J. Exp. Med. 203:15-20.
15. Hotchkiss, R. S., and I. E. Karl. 2003. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348:138-150.
16. Jeffrey, K. L., T. Brummer, M. S. Rolph, S. M. Liu, N. A. Callejas, R. J. Grumont, C. Gillieron, F. Mackay, S. Grey, M. Camps, C. Rommel, S. D. Gerondakis, and C. R. Mackay. 2006. Positive regulation of immune cell function and inflammatory responses by phosphatase PAC-1. Nat. Immunol. 7:274-283.
17. Keyse, S. M. 2000. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr. Opin. Cell Biol. 12:186-192.
18. Lang, R., M. Hammer, and J. Mages. 2006. DUSP meet immunology: dual specificity MAPK phosphatases in control of the inflammatory response. J. Immunol. 177:7497-7504. (Pubitemid 44846262)
19. Misra-Press, A., C. S. Rim, H. Yao, M. S. Roberson, and P. J. Stork. 1995. A novel mitogen-activated protein kinase phosphatase. Structure, expression, and regulation. J. Biol. Chem. 270:14587-14596.
20. Nimah, M., B. Zhao, A. G. Denenberg, O. Bueno, J. Molkentin, H. R. Wong, and T. P. Shanley. 2005. Contribution of MKP-1 regulation of p38 to endotoxin tolerance. Shock 23:80-87. (Pubitemid 40083032)
21. Oberholzer, A., C. Oberholzer, R. M. Minter, and L. L. Moldawer. 2001. Considering immunomodulatory therapies in the septic patient: should apoptosis be a potential therapeutic target? Immunol. Lett. 75:221-224. (Pubitemid 32166778)
22. Ramesh, S., X. J. Qi, G. M. Wildey, J. Robinson, J. Molkentin, J. Letterio, and P. H. Howe. 2008. TGF beta-mediated BIM expression and apoptosis are regulated through SMAD3-dependent expression of the MAPK phosphatase MKP2. EMBO Rep. 9:990-997.
23. Salojin, K. V., I. B. Owusu, K. A. Millerchip, M. Potter, K. A. Platt, and T. Oravecz. 2006. Essential role of MAPK phosphatase-1 in the negative control of innate immune responses. J. Immunol. 176:1899-1907. (Pubitemid 43134335)
24. Sohaskey, M. L., and J. E. Ferrell, Jr. 2002. Activation of p42 mitogen-activated protein kinase (MAPK), but not c-Jun NH(2)-terminal kinase, induces phosphorylation and stabilization of MAPK phosphatase XCL100 in Xenopus oocytes. Mol. Biol. Cell 13:454-468.
25. Stanley, E. R. 1997. Murine bone marrow-derived macrophages. Methods Mol. Biol. 75:301-304.
26. Wang, J., W. H. Shen, Y. J. Jin, P. W. Brandt-Rauf, and Y. Yin. 2007. A molecular link between E2F-1 and the MAPK cascade. J. Biol. Chem. 282:18521-18531.
27. Zhang, T., J. M. Mulvaney, and M. S. Roberson. 2001. Activation of mitogen-activated protein kinase phosphatase 2 by gonadotropin-releasing hormone. Mol. Cell Endocrinol. 172:79-89.
28. Zhang, T., and M. S. Roberson. 2006. Role of MAP kinase phosphatases in GnRH-dependent activation of MAP kinases. J. Mol. Endocrinol. 36:41-50.
29. Zhao, Q., X. Wang, L. D. Nelin, Y. Yao, R. Matta, M. E. Manson, R. S. Baliga, X. Meng, C. V. Smith, J. A. Bauer, C. H. Chang, and Y. Liu. 2006. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J. Exp. Med. 203:131-140.